Skip to main content
. 2021 Dec 24;37(2):300–310. doi: 10.46497/ArchRheumatol.2022.9049

Figure 2. Underlying diseases treated with biological agents. CLL: Chronic lymphocytic leukemia; JIA: Juvenile idiopathic artritis; AS: Ankylosing spondylitis; NHL: Non-Hodgkin lymphoma; IBD: Inflammatory bowel disease; RA: Rheumatoid arthritis.

Figure 2